Cartilage growth factor gains US patents:
This article was originally published in Clinica
Executive Summary
ZymoGenetics has received two US patents covering a growth factor called Zfgf5, which could have a potential in the repair of damaged cartilage tissue. The patents relate to composition of matter for both nucleic acid and protein sequences of Zfgf5, also known in scientific literature as FGF18. These patents demonstrate the company's ability to turn sequence information into proprietary product candidates, says Seattle, Washington firm.